miR-1 detection in adult mouse heart.
miR-1 detection in adult mouse heart.
miR-21 detection in colon adenocarcinoma.
miR-21 detection in colon adenocarcinoma.
miR-122 detection in mouse liver.
miR-122 detection in mouse liver.
miR-124 detection in human brain.
miR-124 detection in human brain.
miR-126 detection in colon wall.
miR-126 detection in colon wall.
miR-145 detection in human colon.
miR-145 detection in human colon.
miR-205 detection in human breast carcinoma.
miR-205 detection in human breast carcinoma.
miR-223 detection in esophagus cancer.
miR-223 detection in esophagus cancer.
Principle of the miRCURY LNA miRNA ISH Optimization Kit (FFPE).
Principle of the miRCURY LNA miRNA ISH Optimization Kit (FFPE).
miRCURY LNA miRNA ISH Kit chooser.
miRCURY LNA miRNA ISH Kit chooser.
miR-1 detection in adult mouse heart. The miRCURY LNA miRNA ISH Optimization Kit 1 was used to detect miR-1 in mouse heart FFPE tissue. Staining was performed with NBT-BCIP (blue). Sections were counterstained with Nuclear Red.
miR-21 detection in colon adenocarcinoma. The miRCURY LNA miRNA ISH Optimization Kit 2 was used to detect miR-21 in colon adenocarcinoma FFPE tissue. Staining was performed with NBT-BCIP (blue). Sections were counterstained with Nuclear Red.
miR-122 detection in mouse liver. The miRCURY LNA miRNA ISH Optimization Kit 3 was used to detect miR-122 in normal murine liver FFPE tissue. Staining was performed with NBT-BCIP (blue). Sections were counterstained with Nuclear Red.
miR-124 detection in human brain. The miRCURY LNA miRNA ISH Optimization Kit 4 was used to detect miR-124 in human brain lesion FFPE tissue. Staining was performed with NBT-BCIP (blue). Sections were counterstained with Nuclear Red.
miR-126 detection in colon wall. The miRCURY LNA miRNA ISH Optimization Kit 5 was used to detect miR-126 in FFPE samples with inflamed colon tissue. Staining was performed with NBT-BCIP (blue). Sections were counterstained with Nuclear Red.
miR-145 detection in human colon. The miRCURY LNA miRNA ISH Optimization Kit 7 was used to detect miR-145 in FFPE tissue of human colon wall with underlying muscle layers. Staining was performed with NBT-BCIP (blue). Sections were counterstained with Nuclear Red.
miR-205 detection in human breast carcinoma. The miRCURY LNA miRNA ISH Optimization Kit 8 was used to detect miR-205 in human breast carcinoma FFPE tissue. Staining was performed with NBT-BCIP (blue). Sections were counterstained with Nuclear Red.
miR-223 detection in esophagus cancer. The miRCURY LNA miRNA ISH Optimization Kit 9 was used to detect miR-223 in FFPE samples with human esophagus cancer. Staining was performed with NBT-BCIP (blue). Sections were counterstained with Nuclear Red.
Principle of the miRCURY LNA miRNA ISH Optimization Kit (FFPE). First, the tissue is "opened" using Protease K. In the hybridization step, the DIG-labeled LNA probe binds specifically to its target miRNA. Alkaline phosphatase (AP)-conjugated anti-DIG antibodies are then added. This step is followed by NBT-BCIP development and optional counterstaining with Nuclear Red.
miRCURY LNA miRNA ISH Kit chooser. Choosing the appropriate miRCURY LNA miRNA ISH Optimization Kit. The table indicates the tissue(s) in which each of the kits has been validated.